Medicare Enrolled
Dr. Bruce Saidman, MD
Hematology & Oncology · Kingston, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saidman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saidman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saidman
Dr. Bruce Saidman is a hematology & oncology specialist in Kingston, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saidman performed 437,138 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Saidman received a total of $4,375 from 44 pharmaceutical and/or device companies across 205 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saidman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in PA
$4,375 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗437,138
Medicare services
Top 0% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
263,250 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 38,200 | $43 | $76 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
24,505 | $2 | $8 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
22,364 | $0 | $5 |
| Nivolumab injection (Opdivo) | 21,720 | $24 | $50 |
| Denosumab injection (Prolia/Xgeva) | 19,500 | $18 | $55 |
| Paclitaxel chemotherapy injection | 13,200 | $0 | $7 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,347 | $0 | $8 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,902 | $1 | $55 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,978 | $8 | $40 |
| Injection, leucovorin calcium, per 50 mg | 2,631 | $3 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,810 | $63 | $150 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,580 | $10 | $37 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
1,157 | $5 | $18 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,072 | $6 | $22 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
958 | $8 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
904 | $97 | $635 |
| Injection, irinotecan, 20 mg | 830 | $2 | $170 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
812 | $17 | $75 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
766 | $22 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
536 | $10 | $100 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
511 | $2 | $225 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
498 | $12 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
465 | $93 | $250 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
446 | $22 | $175 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
444 | $109 | $450 |
| Iron level test | 420 | $6 | $30 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
419 | $8 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
405 | $46 | $325 |
| Injection, atropine sulfate, 0.01 mg | 405 | $0 | $1 |
| Vein or artery injection or infusion Administration of medication or fluid directly into a vein or artery for therapeutic, preventive, or diagnostic purposes. |
389 | $102 | $175 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 381 | $3 | $180 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
368 | $49 | $250 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
303 | $0 | $15 |
| Injection, potassium chloride, per 2 meq | 301 | $0 | $2 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
285 | $1 | $2 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
274 | $10 | $100 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
266 | $53 | $275 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 196 | $129 | $621 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
188 | $1 | $10 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
173 | $97 | $374 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
172 | $1 | $2 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
158 | $62 | $169 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
147 | $23 | $175 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
125 | $6 | $24 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
108 | $1 | $39 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
104 | $16 | $85 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
101 | $7 | $309 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
96 | $29 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
85 | $77 | $250 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
83 | $75 | $98 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
81 | $8 | $30 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
77 | $42 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $132 | $438 |
| 5% dextrose/water (500 ml = 1 unit) | 61 | $1 | $16 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
50 | $4 | $16 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
46 | $42 | $250 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
42 | $5 | $18 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
42 | $4 | $14 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
38 | $38 | $106 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
35 | $2 | $20 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
32 | $65 | $225 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
29 | $3 | $12 |
| New patient office visit, complex (60-74 min) | 28 | $165 | $475 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $130 | $350 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
24 | $5 | $17 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
22 | $25 | $350 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
19 | $118 | $500 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
19 | $15 | $125 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
18 | $1 | $17 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $102 | $321 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $140 | $325 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 13 | $20 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
61.0% high complexity
35.9% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,375
Total received (2018-2024)
Avg $625/year across 7 years
Top 36% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
205
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$854
2023
$1,067
2022
$916
2021
$463
2020
$280
2019
$482
2018
$314
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$331
PFIZER INC.
$168
GlaxoSmithKline, LLC.
$74
Celgene Corporation
$52
Merck Sharp & Dohme LLC
$49
ARRAY BIOPHARMA INC
$47
ABBVIE INC.
$41
PUMA BIOTECHNOLOGY, INC.
$26
Bayer Healthcare Pharmaceuticals Inc.
$19
Aveo Pharmaceuticals, Inc.
$17
GENZYME CORPORATION
$15
SOBI, INC
$14
Top 3 companies account for 67.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,107
PFIZER INC.
$449
Genentech USA, Inc.
$400
NOVARTIS PHARMACEUTICALS CORPORATION
$250
Astellas Pharma US Inc
$199
Alexion Pharmaceuticals, Inc.
$191
Merck Sharp & Dohme LLC
$162
Celgene Corporation
$136
GlaxoSmithKline, LLC.
$111
ARRAY BIOPHARMA INC
$97
Kite Pharma, Inc.
$93
AstraZeneca Pharmaceuticals LP
$90
Pharmacyclics LLC, An AbbVie Company
$88
Merck Sharp & Dohme Corporation
$82
Amgen Inc.
$80
Bayer HealthCare Pharmaceuticals Inc.
$71
E.R. Squibb & Sons, L.L.C.
$64
Gilead Sciences, Inc.
$55
Daiichi Sankyo Inc.
$46
Foundation Medicine, Inc.
$44
Organon LLC
$43
GENZYME CORPORATION
$42
ABBVIE INC.
$41
Incyte Corporation
$38
Seattle Genetics, Inc.
$33
Ipsen Biopharmaceuticals, Inc
$32
Pharmacyclics LLC, an AbbVie Company
$30
Janssen Biotech, Inc.
$30
PUMA BIOTECHNOLOGY, INC.
$26
AbbVie Inc.
$24
BeiGene USA, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
Aveo Pharmaceuticals, Inc.
$17
AVEO Pharmaceuticals, Inc.
$16
Lilly USA, LLC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
SOBI, INC
$14
Dova Pharmaceuticals
$14
Progenics Pharmaceuticals, Inc.
$14
Seagen Inc.
$13
Heron Therapeutics, Inc.
$13
Karyopharm Therapeutics Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$11
Top 3 companies account for 44.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · Abraxane · Alecensa · Aliqopa · Avastin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CALQUENCE · Columvi · DOPTELET · Doptelet · ELIQUIS · ENJAYMO · EPKINLY · EVENITY · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Gazyva · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · LIBTAYO · LORBRENA · LUPRON DEPOT · LYNPARZA · MEKINIST · MONJUVI · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · PADCEV · PIQRAY · PROMACTA · PYLARIFY · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · REBLOZYL · RETEVMO · Revlimid · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · Somatuline Depot · Sustol · TAGRISSO · TECENTRIQ · Trodelvy · VENCLEXTA · Venclexta · XALKORI · XOSPATA · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
18
County median income
$62,321
Nearest hospital to ZIP centroid (approximate)
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
12.5 mi
12.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saidman is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saidman experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Saidman performed 263,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Saidman receive payments from pharmaceutical companies?
Yes. Dr. Saidman received a total of $4,375 from 44 companies across 205 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saidman's costs compare to other hematology & oncology specialists in Kingston?
Dr. Saidman's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saidman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Kingston
Browse hematology & oncology specialists in Kingston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology